How useful are monogenic rodent models for the study of human non-alcoholic fatty liver disease?
Improving understanding of the genetic basis of human non-alcoholic fatty liver disease (NAFLD) has the potential to facilitate risk stratification of affected patients, permit personalised treatment, and inform development of new therapeutic strategies. Animal models have been widely used to interr...
Main Authors: | Jake Peter Mann, Robert Kenneth Semple, Matthew J Armstrong |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2016-11-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fendo.2016.00145/full |
Similar Items
-
Transient hepatic elastography has the best performance to evaluate liver fibrosis in non-alcoholic fatty liver disease (NAFLD)
by: Cristiane V. Tovo, et al.
Published: (2019-05-01) -
New Onset Diabetes and Non-Alcoholic Fatty Liver Disease after Liver Transplantation
by: Antônio R. Andrade, et al.
Published: (2017-11-01) -
Dietary Polyphenolsand Non-Alcoholic Fatty Liver Disease
by: Ludovico Abenavoli, et al.
Published: (2021-02-01) -
Nuts and Non-Alcoholic Fatty Liver Disease: Are Nuts Safe for Patients with Fatty Liver Disease?
by: Maria Corina Plaz Torres, et al.
Published: (2020-11-01) -
Non-alcoholic Steatohepatitis: An Overview
by: Allison Shifflet, et al.
Published: (2009-01-01)